For those here who were in both TSRX and DRTX they will remember well that neither stock shot up straight line... Those early in both saw the stocks stagnate at single digit levels for quite some time...Then they gradually moved up into low double digits on good trial news...then with TSRX, we woke up one morning and the stock was being taken over in the $16's... DRTX had a similar story and moved from single digits to around $17 over time...then it actually corrected sharply down to the $12-$13 level for no reason, and shortly thereafter we all woke up one morning to see a $23 plus buyout.
Bottom line....Just stay with it. Add on weakness. You'll be rewarded down the line bigtime... IMHO!!
Analysts are unforgiving. They got bagged in this name as the #1 MLP to own in this downturn and the dismal quarterly report and the cut in the dividend just about did their clients in (together with the 50% drop in share price). Almost all the MLPs were up big today...4%-10% and MEMP....? .53%? LOL....
Going to take at least a quarter, but more likely two, to get back even near the $10 area. Management is going to have to show they can cut expenses significantly and move the bottom line back up. Without improved results we're looking at a $5-$7 stock for at least the next 12 months.Can you even imagine where
this name would be without the best hedges in the industry??
The only production that if interrupted could help us now would be that of the fat pig Saudis...Maybe we should let Isis do their thing over there for a few weeks and let them take their oil fields, then blow them all to hell!
What it means Silver IMHO is for all longs to relax....Don't go over board on this recent move....We've been here before, and we all remember what happened then.....Remind yourself what the end game is here (a buyout), and that everything before that, up or down, is just noise. All that matters is that the Phase 3 reults are good...We file for an NDA ASAP...That we file forapproval for numerous indications....That we get approvals....Then everything else will take care of itself. Trust me.
Everyone here could do would be to find a deserted island someplace with no internet...tv...phones...etc.
and come back eighteen months from now THEN sell or tender your CEMP shares....! This day to day stuff will not only drive you nuts but more than likely at some point drive you out of the stock, which you WILL regret. That my friends is a given IMHO..........
OK...all we've heard is that MEMP is the golden child for the upstream MLP's (the best in the worst neighborhood), then they put out a quarter like the last one and you realize these jokers couldn't manage
their way out of a paper bag. Expenses were up when almost everyone's elses were down, and some down big. Even BBEP, the most leveraged of them all, had a very good quarter expense wise.
Face it...We need new management at ol MEMP. These idiots think that a good hedging program is going
to make everything ok and they can just continue on with their big salaries and big spending ways until oil
recovers to $110 in a few years. Their gravy train has left the station. Hate to tell them it's time to grow up and learn to manage, or get the heck out. Time is not on our side nor on anyone eles's in this mess...
Full report on Twitter at "dougheuring" citing the HiddenGemTrader...CEMP more.... About half way down the page....
Sentiment: Strong Buy
Karen....This time last year the stock was selling above $22. Although oil is approx 50% off it's 2014 highs, the current dividend is approx. 75% off from the one of July, 2014. At the selling price of BBEP back in July, 2014, the current dividend would reflect a yield of approx 2.3%.. To call that rate excessive even under current oil prices is just pure bunk. Given their current hedges and the ones expected for 2016, the company can easily afford the current dividend, if not more.
I think we need to remember that the goal literally is non inferiority to Moxi...Our safety profile alone will make it the antibiotic of choice.
CEMP is heavily followed by the tech gurus. The chart was looking very positive a few weeks back heading towards the 37 area to possibly again challenge 40 plus. Traders are playing this pretty well. Buying on market corrections and selling a few points higher. Nothing much to hurt shorts in the near term either, news wise, so that trade is also probably also in play on any meaningful rallies.
As for the stock...Just consolidating in a narrow trading range for many weeks now. Will either break out to the upside eventually or break down. I have alot of dough on the line saying the former. Not worried one iota.
Sentiment: Strong Buy
CEMP marketing and PR has become "lazy and arrogant....indifferent"?
Maybe they know what the end game really is, and they could care less about interim stock moves or if investors get in or not. DRTX...TSRX same deal. Stocks initially ran on some good Phase II results, then moved sideways for a long time during Phase III trials.
The end game here is a buyout IMHO. Problem at this point is valuation. If SOLI gets approvals for a lot of other indications down the road the value could be 75%-100% higher than it is today. So management has no real need to pump or promote the stock. Can use the funds better for development of product and general corporate purposes.
We haven't even touched European approvals and markets yet. Do we go out and try to get a European marketing partner now or simply sell to a multi national and not bother? We are working on approvals and trials on so many fronts now at the same time it's like fighting WWII all by yourself...lol! So no real time or funds really to devote to major stock PR campaigns, and probably no real reason to do so frankly.
Yes...It can be frustrating to shareholders, no doubt about that. But just remember, it's patience then patients, all all will be fine... In fact, more than fine IMHO..
Let's think about this.... In economic turmoil and uncertainty, would you rather be in a biotech that has no immediate expectations of earnings, or in some multi national mfg or producer of goods and services that relies in part on the strength of Europe for their earnings and projected growth?
Actually better off in a good bio whose earnings are a few years out and whose demand is based on patient and hospital needs, rather than consumers consumption.... You can put off buying a new car, but you can't put off stopping a major infection that can kill you.....
Also....We are in late stage trials with Soli and the CEO needs to be very careful as to what she is saying
about trials and due dates and particularly, prospective results, etc. No need to screw up with the FDA at this juncture to promote the stock in any way. That will take care of itself. Keep your fingers crossed is about as bland as it can be but what else can she really say at this juncture?
If you had worked your entire life behind the drug counter at Rite Aide like pharma has done, you'd be
ticked off too that all the longs here have already made a killing on this stock....LOL!
Happy weekend all. At least his presence gave us all some comic relief this week....